These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37256643)

  • 1. FDA Greenlights Automated Insulin Dosing System for Type 1 Diabetes.
    Harris E
    JAMA; 2023 Jun; 329(23):2011. PubMed ID: 37256643
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.
    Forlenza GP
    Diabetes Technol Ther; 2017 Apr; 19(4):206-208. PubMed ID: 28418732
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin Pumps.
    Pickup JC
    Diabetes Technol Ther; 2018 Feb; 20(S1):S30-S40. PubMed ID: 29437475
    [No Abstract]   [Full Text] [Related]  

  • 4. Closing the Loop.
    Nimri R; Audon P; Pinsker JE; Dassau E
    Diabetes Technol Ther; 2018 Feb; 20(S1):S41-S54. PubMed ID: 29437478
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes Technology and the Human Factor.
    Liberman A; Barnard K
    Diabetes Technol Ther; 2018 Feb; 20(S1):S128-S138. PubMed ID: 29437474
    [No Abstract]   [Full Text] [Related]  

  • 6. Large Treatment Effects With Automated Insulin Delivery System.
    Slomski A
    JAMA; 2022 Oct; 328(16):1581-1582. PubMed ID: 36282258
    [No Abstract]   [Full Text] [Related]  

  • 7. Technology and Pregnancy.
    Yamamoto JM; Murphy HR
    Diabetes Technol Ther; 2018 Feb; 20(S1):S94-S103. PubMed ID: 29437483
    [No Abstract]   [Full Text] [Related]  

  • 8. Open-source Closed-Loop System Is Effective for Type 1 Diabetes.
    Larkin HD
    JAMA; 2022 Oct; 328(14):1387-1388. PubMed ID: 36219416
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of emerging new technologies.
    Garg SK
    Diabetes Technol Ther; 2008 Oct; 10(5):413-4. PubMed ID: 18715219
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-term glucose variability in adults with Type 1 diabetes does not differ between insulin pump and multiple daily injection users - a masked continuous glucose monitoring study in clinical practice.
    Scott ES; McGrath RT; Januszewski AS; Fulcher GR; Jenkins AJ
    Diabetes Metab; 2020 Apr; 46(2):172-174. PubMed ID: 29937359
    [No Abstract]   [Full Text] [Related]  

  • 11. [Insulin doses adaptation with insulin Lys-pro in external pump].
    Grimaldi A; Sachon C; Timsit J
    Diabetes Metab; 2001 Jun; 27(3):386-7. PubMed ID: 11431606
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternative insulin delivery systems: how demanding should the patient be?
    Polonsky KS; Byrne MM; Sturis J
    Diabetologia; 1997 Jul; 40 Suppl 2():S97-101. PubMed ID: 9248709
    [No Abstract]   [Full Text] [Related]  

  • 13. Cybersecurity Risk for Medtronic Insulin Pump.
    Larkin HD
    JAMA; 2022 Nov; 328(17):1679. PubMed ID: 36318151
    [No Abstract]   [Full Text] [Related]  

  • 14. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC
    Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
    Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM
    Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time in tight range in automated insulin delivery system users: Real-world data from children and adolescents with type 1 diabetes.
    Piona C; Passanisi S; Bombaci B; Marigliano M; Lombardo F; Mancioppi V; Morandi A; Maffeis C; Salzano G;
    Diabetes Obes Metab; 2024 Oct; 26(10):4767-4771. PubMed ID: 39021339
    [No Abstract]   [Full Text] [Related]  

  • 17. A Mobile Application Guiding Patients With Type 1 Diabetes Using Sensor-Augmented Insulin Pump Therapy.
    Esvant A; Lefebvre MA; Campillo-Gimenez B; Lannes M; Delamarre D; Guilhem I; Poirier JY
    J Diabetes Sci Technol; 2016 Jul; 10(4):985-6. PubMed ID: 26902791
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous Glucose Monitoring in 2016.
    Bode BW; Battelino T
    Diabetes Technol Ther; 2017 Feb; 19(S1):S11-S18. PubMed ID: 28192020
    [No Abstract]   [Full Text] [Related]  

  • 19. Artificial Pancreas Improved Outcomes in Children With Type 1 Diabetes.
    Harris E
    JAMA; 2023 Apr; 329(15):1249. PubMed ID: 36988977
    [No Abstract]   [Full Text] [Related]  

  • 20. MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias: Response to Inaccurate Allegations.
    van den Heuvel T; Castaneda J; Thijs I; Arrieta A; Lintereur L; Shin J; Cohen O
    Diabetes Technol Ther; 2024 Oct; 26(10):783-784. PubMed ID: 38563714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.